Headaches treatment with EMG biofeedback: a focused systematic review and meta-analysis.

ABSTRACT:

Introduction

The aim of this paper was to present an up-to-date evaluation of the efficacy of EMG-biofeedback (EMG-BFB) for primary headaches and to address possible mediators of outcome.

Evidence acquisition

PubMed, Scopus, Embase and Pedro databases were searched from inception to May 1, 2023. All randomized controlled trials (RCT) studies using an EMG-BFB to treat headache have been included in this systematic review. The current systematic review was performed following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) recommendations and was registered in the PROSPERO database (CRD42022312827). Methodological quality was assessed through the Risk of Bias tool 2 (RoB 2). The effect sizes and 95% confidence interval (CI) were calculated by random

SUBMITTER: Martino Cinnera A 

PROVIDER: S-EPMC10797640 | biostudies-literature | 2023 Dec

REPOSITORIES: biostudies-literature